• A Case of Congenital Myasthenia Gravis due to ChAT Gene Mutation in a Term Neonate: A Case Report
• A family with early onset myopathy caused by MEGF10 gene defect and literature review
• A novel <em>DOK7</em> mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members
• A novel DOK7 mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members
• A Rare Case of Lambert-Eaton Myasthenia Syndrome Associated with Non-Hodgkin's Lymphoma: A Case Report and Review of the Literature
• Alteration of serum bile acids in amyotrophic lateral sclerosis
• Altered gut microbiota and metabolites in untreated myasthenia gravis patients
• Analysis of clinical characteristics and related genetic variation of juvenile myasthenia gravis
• Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis
• Association between systemic lupus erythematosus and myasthenia gravis: A population-based National Study
• Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis
• Autoimmune Diseases in Patients With Myotonic Dystrophy Type 2
• Causal relationship between gut microbiota and myasthenia gravis: a bidirectional mendelian randomization study
• Causal relationship between gut microbiota and myasthenia gravis: a two-sample Mendelian randomization study
• Clinical characteristics and genetic analysis of a child with Neutral lipid storage disease with myopathy
• Clinical characteristics of anti-CV2 antibody-associated neurological diseases
• Clinical delineation of myasthenia gravis in the Kingdom of Bahrain
• Clinical spectrum of myasthenia gravis: An institute experience over 8 years from North East India
• Clinical, Histological, and Genetic Features of 25 Patients with Autosomal Dominant Progressive External Ophthalmoplegia (ad-PEO)/PEO-Plus Due to <em>TWNK</em> Mutations
• Comparative the efficacy and acceptability of immunosuppressive agents for myasthenia gravis: A protocol for systematic review and network meta-analysis
• Comparison of Short-Term Post-Thymectomy Outcomes by Time-Weighted Dosages of Drug Requirements between Thymoma and Non-Thymoma Myasthenia Gravis Patients
• Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families
• DCAF12 and HSPA1A May Serve as Potential Diagnostic Biomarkers for Myasthenia Gravis
• Decision for early tracheostomy in respiratory failure of a paralyzed myasthenia gravis patient with sepsis-induced pneumonia: A case report
• Developing the health state classification system for a condition-specific preference-based measure for patients with myasthenia gravis
• Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK
• Development of a standard of care for patients with valosin-containing protein associated multisystem proteinopathy
• Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells
• Dynamics of patents, orphan drug designation, licensing, and revenues from drugs for rare diseases: The market expansion of eculizumab
• Effect of Fufang Huangqi Decoction on the Gut Microbiota in Patients With Class I or II Myasthenia Gravis
• Effects of Qishen Dihuang Granules on Intestinal Microbiota in Experimental Autoimmune Myasthenia Gravis Model Rats
• Evidence for genetic causal relationships between gut microbiome, metabolites, and myasthenia gravis: a bidirectional Mendelian randomization study
• Experience of Daily Life with Generalized Myasthenia Gravis: A Qualitative Investigation and Assessment of Instrument Content Validity
• Explainable machine learning model for identifying key gut microbes and metabolites biomarkers associated with myasthenia gravis
• Factors associated with the disease family burden of caregivers of myasthenia gravis patients in northwestern China: A cross-sectional study
• Familial autoimmunity in patients with idiopathic inflammatory myopathies
• Family Game Show-style Didactic for Teaching Nervous System Disorders during Emergency Medicine Training
• Fetal Surveillance in Pregnancies with Myasthenia Gravis
• Five-Month Trial of Whole-Food Plant-Based Diet in a Patient With Coexisting Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome
• FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
• Genetic analysis of a Chinese pedigree affected with atypical Charcot-Marie-Tooth disease type 1A due to duplication of PMP22 gene
• Genetic analysis of a family affected by congenital myasthenic syndrome due to a Novel mutation in the SLC5A7 gene
• GFPT1-Associated Congenital Myasthenic Syndrome Mimicking a Glycogen Storage Disease - Diagnostic Pitfalls in Myopathology Solved by Next-Generation-Sequencing
• Idiopathic multicentric Castleman disease and associated autoimmune and autoinflammatory conditions: practical guidance for diagnosis
• Ileus at Altitude
• Immune checkpoint inhibitor-induced myocarditis with myasthenia gravis overlap syndrome: A case report and literature review
• Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
• Implications of COVID-19 On A Rapidly Growing Thymoma Case
• Improving the efficacy of exome sequencing at a quaternary care referral centre: novel mutations, clinical presentations and diagnostic challenges in rare neurogenetic diseases
• Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies
• JNO Literature Commentary
• Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis
• Lower BAFF Levels in Myasthenic Patients Treated with Glucocorticoids
• Machine learning strategy for identifying altered gut microbiomes for diagnostic screening in myasthenia gravis
• Mechanisms of Congenital Myasthenia Caused by Three Mutations in the <em>COLQ</em> Gene
• Mechanisms of Congenital Myasthenia Caused by Three Mutations in the COLQ Gene
• Mendelian randomization study revealed a gut microbiota-neuromuscular junction axis in myasthenia gravis
• Mental health in myasthenia gravis patients and its impact on caregiver burden
• Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis
• Myasthenia gravis and economic burden: Exploring the impact of family dynamics on financial strain
• Myasthenia gravis-Gender aspects and family planning
• Neuromyelitis Optica Spectrum Disorder
• New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report
• Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
• Nivolumab, a Double-Edged Sword: A Case Report of Nivolumab-Induced Myasthenia Gravis
• Office-based respiratory assessment in patients with generalized myasthenia gravis
• Outcome of therapeutic plasma exchange in Myasthenia gravis patients
• Pediatric Neuromuscular Diseases
• Perry Syndrome with a Novel Mutation and a Rare Presentation: First Report from India
• Placental inflammatory injury induced by chlorinated polyfluorinated ether sulfonate (F-53B) through NLRP3 inflammasome activation
• POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinoma
• Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study
• Prenatal diagnosis of isolated bilateral clubfoot: Is amniocentesis indicated?
• Prevalence of depression among Iranian patients with myasthenia gravis during 2017-2018
• Provisional practice recommendation for the management of myopathy in VCP-associated multisystem proteinopathy
• Psychopharmacological Treatments for Mental Disorders in Patients with Neuromuscular Diseases: A Scoping Review
• Ptosis Correction
• Ptosis Correction
• Rechallenge of immune checkpoint inhibitors in a case with adverse events inducing myasthenia gravis
• Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis
• Rituximab in the Management of Refractory Myasthenia Gravis and Variability of Its Efficacy in Anti-MuSK Positive and Anti-AChR Positive Myasthenia Gravis
• Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems
• Seronegative Ocular Myasthenia Gravis in an Older Woman With Transient Dizziness and Diplopia
• Serum Pentaxin 3 (PTX3) Promotes NLRP3 Inflammasome and Pyroptosis in Patients with Up-Regulated Myasthenia Gravis
• Serum pentraxin 3 concentration correlates with disease severity in patients with myasthenia gravis
• Should We Consider Routine Blood Work for Diplopia and Ptosis in a Primary Care Setting?
• Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
• Special Issue: Immune-Mediated Neurological Disorders
• Study of seasonality of attacks in MOG antibody-associated disease
• The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis
• The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study
• The burden of myasthenia gravis - highlighting the impact on family planning and the role of social support
• The investigation of killer-cell immunoglobulin-like receptors (KIRs) and their HLA ligands in Iranian patients with myasthenia gravis
• The Parallel World of Dyspnea: A Case Report
• Thyrotoxic hypokalemic periodic paralysis and COVID-19 infection
• Transient Neonatal Myasthenia Gravis Born to a Mother with Asymptomatic MG: A Case Report
• Transient Neonatal Myasthenia Gravis: A Case Report
• Understanding the Symptom Burden and Impact of Myasthenia Gravis from the Patient's Perspective: A Qualitative Study
• Unraveling the Immune Microenvironment of Thymic Epithelial Tumors: Implications for Autoimmunity and Treatment
• Whole-exome sequencing and human leukocyte antigen analysis in familial myasthenia gravis with thymoma: Case report and literature review